The immunomagnetic enrichment of ASGPR+ CTCs and subsequent identification by immunofluorescence staining with Hep Par 1 antibody were illustrated to be an effective strategy to identify CTCs from peripheral blood of HCC patients. The gene discussed is ASGR1; the disease is hepatocellular carcinoma.